Effectiveness and safety of recombinant human erythropoietin beta in maintaining common haemoglobin targets in routine clinical practice in Europe: the GAIN study

ABSTRACT Objective: The Gain effectiveness in Anaemia treatment wIth NeoRecormon* (epoetin beta) study (GAIN) evaluated the effectiveness and safety of recombinant human erythropoietin beta in correcting and/or maintaining common haemoglobin (Hb) targets in routine clinical practice in Europe. *NeoR...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current medical research and opinion 2009-04, Vol.25 (4), p.961-970
Hauptverfasser:	Rath, Thomas, Mactier, Robert A., Weinreich, Thomas, Scherhag, Armin W.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Anaemia Anemia - drug therapy Anemia - etiology Chronic kidney disease Epoetin beta Erythropoietin - administration & dosage Erythropoietin - adverse effects Erythropoietin - therapeutic use Europe GAIN Haemoglobin Hemoglobins - drug effects Hemoglobins - metabolism Humans Injections, Intravenous Injections, Subcutaneous Kidney Failure, Chronic - complications Kidney Failure, Chronic - etiology Middle Aged Recombinant Proteins Renal Dialysis Retrospective Studies Safety Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!